Rosenberg Anthony 4
4 · Cullinan Therapeutics, Inc. · Filed Jun 27, 2024
Insider Transaction Report
Form 4
Rosenberg Anthony
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-26+15,806→ 15,806 totalExercise: $16.50Exp: 2034-06-26→ Common Stock (15,806 underlying)
Footnotes (1)
- [F1]The option represents a right to purchase a total of 15,806 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 26, 2025 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date.